Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference

March 7, 2013

MINNEAPOLIS, March 7, 2013 /PRNewswire/ — Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen, President and CEO, and Darin Hammers, Vice President of US Sales, will present the Company’s business strategy and financial results at the 25th Annual ROTH Growth Stock Conference at 8:30 AM PT on Monday, March 18, 2013 at The Ritz Carlton in Dana Point, CA.

Attendance at the conference is by invitation only. A live audio webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at http://wsw.com/webcast/roth27/upi/ or through Uroplasty’s website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, a urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Please visit Uroplasty, Inc. at www.uroplasty.com.

    For Further Information:

                                   EVC Group

    Uroplasty, Inc.

                                    Doug Sherk/Jenifer Kirtland
                                    (Investors),

    David Kaysen, President and
     CEO, or                       415-568-9349

    Medi Jiwani, Vice President,    Amy Phillips (Media),
     CFO, Treasurer                 412-327-9499

    952-426-6140
    ------------

SOURCE Uroplasty, Inc.


Source: PR Newswire